Literature DB >> 17011764

TIM-3 in autoimmunity.

Ana C Anderson1, David E Anderson.   

Abstract

T cell immunoglobulin and mucin domain (TIM)-3 is a molecule expressed on terminally differentiated murine Th1 cells but not on Th2 cells. Identification of galectin-9 as a ligand for TIM-3 has now firmly established the TIM-3-galectin-9 pathway as an important regulator of Th1 immunity and tolerance induction. TIM-3 is similarly expressed on human Th1 cells and not on Th2 cells, which suggests that TIM-3 might also contribute to Th1 regulation in humans. In addition, genetic data associate the TIM locus and specific TIM-3 polymorphisms with various immune-mediated diseases. Most importantly, recent data suggest a novel paradigm in which dysregulation of the TIM-3-galectin-9 pathway could underlie chronic autoimmune disease states, such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011764     DOI: 10.1016/j.coi.2006.09.009

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  38 in total

1.  Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

Authors:  Shipra Gupta; Thomas B Thornley; Wenda Gao; Rafael Larocca; Laurence A Turka; Vijay K Kuchroo; Terry B Strom
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

2.  Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28.

Authors:  Zohreh Koohini; Hadi Hossein-Nataj; Maryam Mobini; Aref Hosseinian-Amiri; Alireza Rafiei; Hossein Asgarian-Omran
Journal:  Clin Rheumatol       Date:  2018-04-07       Impact factor: 2.980

3.  A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.

Authors:  John A Mengshol; Lucy Golden-Mason; Tomohiro Arikawa; Maxwell Smith; Toshiro Niki; Ryan McWilliams; Jessica A Randall; Rachel McMahan; Michael A Zimmerman; Manu Rangachari; Evgenia Dobrinskikh; Pierre Busson; Stephen J Polyak; Mitsuomi Hirashima; Hugo R Rosen
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

4.  TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions.

Authors:  Pradeep B J Reddy; Taylor H Schreiber; Naveen K Rajasagi; Amol Suryawanshi; Sachin Mulik; Tamara Veiga-Parga; Toshiro Niki; Mitsuomi Hirashima; Eckhard R Podack; Barry T Rouse
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model.

Authors:  Siyu Xiao; Jinfeng Liu; Shiguang Huang; Fangli Lu
Journal:  Parasitol Res       Date:  2016-02       Impact factor: 2.289

6.  Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo.

Authors:  Manoj Kumar Tembhre; Anita Singh Parihar; Alpana Sharma; Somesh Gupta; Parthaprasad Chattopadhyay; Vinod Kumar Sharma
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

7.  Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.

Authors:  Jeongsu Do; Dongkyun Kim; Sohee Kim; Alice Valentin-Torres; Nina Dvorina; Eunjung Jang; Vivekananthan Nagarajavel; Tara M DeSilva; Xiaoxia Li; Angela H Ting; Dario A A Vignali; Stephen A Stohlman; William M Baldwin; Booki Min
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

8.  Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats.

Authors:  Dingtai Wei; Xiaoxing Xiong; Heng Zhao
Journal:  Metab Brain Dis       Date:  2014-04-29       Impact factor: 3.584

9.  In primed allo-tolerance, TIM-3-Ig rapidly suppresses TGFbeta, but has no immediate effect on Foxp3.

Authors:  Poorni A D S Muthukumarana; Xin X Zheng; Bruce R Rosengard; Terry B Strom; Susan M Metcalfe
Journal:  Transpl Int       Date:  2008-02-16       Impact factor: 3.782

10.  Imbalanced expression of T-bet and T cell immunoglobulin mucin-3 in patients with aplastic anaemia.

Authors:  Ning-ning Shan; Yu Hu; Xin Liu; Xin Wang; Dai Yuan; Ying Li
Journal:  J Clin Immunol       Date:  2013-01-19       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.